Kellen Scott
SEC CIK 1490476 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | CFO, Sec | 32.3K | $70.6K | — | 2 | 2021-08-16 | 2023-06-23 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
Kellen Scott made no open-market trades at DMAC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Kellen Scott | CFO, Sec | P - Purchase | $3.91 | +10.0K | 32.3K | +45% | +$39.1K | |
| 2021-08-16 | 2021-08-16 | DMAC | DiaMedica Therapeutics Inc. | Kellen Scott | CFO, Sec | P - Purchase | $3.15 | +10.0K | 22.3K | +81% | +$31.5K |
Purchase Sale Sale after option exercise All abbreviations